rs150174842

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS1

The NM_006949.4(STXBP2):​c.1459G>A​(p.Val487Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000326 in 1,611,864 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V487L) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0017 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00018 ( 0 hom. )

Consequence

STXBP2
NM_006949.4 missense

Scores

1
9
9

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:2

Conservation

PhyloP100: 2.33

Publications

4 publications found
Variant links:
Genes affected
STXBP2 (HGNC:11445): (syntaxin binding protein 2) This gene encodes a member of the STXBP/unc-18/SEC1 family. The encoded protein is involved in intracellular trafficking, control of SNARE (soluble NSF attachment protein receptor) complex assembly, and the release of cytotoxic granules by natural killer cells. Mutations in this gene are associated with familial hemophagocytic lymphohistiocytosis. Alternatively spliced transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Jan 2013]
STXBP2 Gene-Disease associations (from GenCC):
  • familial hemophagocytic lymphohistiocytosis 5
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG, LIMITED Submitted by: Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae)
  • hereditary hemophagocytic lymphohistiocytosis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • microvillus inclusion disease
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.01370734).
BP6
Variant 19-7647168-G-A is Benign according to our data. Variant chr19-7647168-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 719480.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00173 (263/152328) while in subpopulation AFR AF = 0.00606 (252/41588). AF 95% confidence interval is 0.00544. There are 0 homozygotes in GnomAd4. There are 118 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
STXBP2NM_006949.4 linkc.1459G>A p.Val487Met missense_variant Exon 17 of 19 ENST00000221283.10 NP_008880.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
STXBP2ENST00000221283.10 linkc.1459G>A p.Val487Met missense_variant Exon 17 of 19 1 NM_006949.4 ENSP00000221283.4
ENSG00000268400ENST00000698368.1 linkn.*1562G>A non_coding_transcript_exon_variant Exon 19 of 20 ENSP00000513686.1
ENSG00000268400ENST00000698368.1 linkn.*1562G>A 3_prime_UTR_variant Exon 19 of 20 ENSP00000513686.1

Frequencies

GnomAD3 genomes
AF:
0.00173
AC:
263
AN:
152210
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00608
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000523
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.000957
GnomAD2 exomes
AF:
0.000424
AC:
103
AN:
242894
AF XY:
0.000286
show subpopulations
Gnomad AFR exome
AF:
0.00513
Gnomad AMR exome
AF:
0.000233
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000557
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000371
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000180
AC:
263
AN:
1459536
Hom.:
0
Cov.:
30
AF XY:
0.000157
AC XY:
114
AN XY:
726092
show subpopulations
African (AFR)
AF:
0.00553
AC:
185
AN:
33458
American (AMR)
AF:
0.000291
AC:
13
AN:
44710
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26118
East Asian (EAS)
AF:
0.000353
AC:
14
AN:
39692
South Asian (SAS)
AF:
0.0000928
AC:
8
AN:
86234
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
51818
Middle Eastern (MID)
AF:
0.000189
AC:
1
AN:
5296
European-Non Finnish (NFE)
AF:
0.0000234
AC:
26
AN:
1111892
Other (OTH)
AF:
0.000265
AC:
16
AN:
60318
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
17
34
52
69
86
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00173
AC:
263
AN:
152328
Hom.:
0
Cov.:
33
AF XY:
0.00158
AC XY:
118
AN XY:
74488
show subpopulations
African (AFR)
AF:
0.00606
AC:
252
AN:
41588
American (AMR)
AF:
0.000522
AC:
8
AN:
15312
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5172
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10628
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68016
Other (OTH)
AF:
0.000947
AC:
2
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
13
26
40
53
66
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000156
Hom.:
0
Bravo
AF:
0.00210
ESP6500AA
AF:
0.00798
AC:
35
ESP6500EA
AF:
0.000117
AC:
1
ExAC
AF:
0.000495
AC:
60
EpiCase
AF:
0.00
EpiControl
AF:
0.0000593

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Autoinflammatory syndrome Uncertain:1
Jun 01, 2018
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

STXBP2-related disorder Benign:1
Mar 11, 2022
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Familial hemophagocytic lymphohistiocytosis 5 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.29
T
BayesDel_noAF
Benign
-0.19
CADD
Uncertain
23
DANN
Uncertain
1.0
DEOGEN2
Benign
0.22
.;T;.;T
Eigen
Uncertain
0.33
Eigen_PC
Uncertain
0.28
FATHMM_MKL
Benign
0.50
N
LIST_S2
Pathogenic
0.98
D;D;D;D
M_CAP
Uncertain
0.16
D
MetaRNN
Benign
0.014
T;T;T;T
MetaSVM
Uncertain
0.0029
D
MutationAssessor
Benign
1.0
.;L;.;.
PhyloP100
2.3
PrimateAI
Uncertain
0.55
T
PROVEAN
Benign
-2.0
N;N;N;.
REVEL
Uncertain
0.54
Sift
Uncertain
0.015
D;D;D;.
Sift4G
Uncertain
0.031
D;D;D;D
Polyphen
1.0, 0.99
.;D;D;.
Vest4
0.49
MVP
0.79
MPC
0.30
ClinPred
0.028
T
GERP RS
4.0
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.34
gMVP
0.55
Mutation Taster
=81/19
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs150174842; hg19: chr19-7712054; COSMIC: COSV108782890; COSMIC: COSV108782890; API